Skip to main content

YMC 5 Year Vision

YMC’s Corporate Vision was recently articulated by YMC President Ryuji Yamamura, and published in an issue of Newsweek International.

In the article, Mr. Yamamura points out that, “… the greatest strength of YMC’s business model is that we are uniquely positioned to offer our customers a platform that allows them to determine which packing materials, which devices/system/instruments, and which methods can be applied to achieve maximum production efficiency.”

The article can be found here.

Posted on April 29, 2021.

Related Posts

February 16, 2023


YMC America recently hosted colleagues from Japan for a two-week training on YMC’s patented process scale Contichrom TWIN MCSGP technology to support the growing demand in Asia.  We may live on different continents, but we are one YMC family!
YMC’s BioPro is a Reliable Tool for Analyzing PEGylated Proteins

January 15, 2022

YMC’s BioPro is a Reliable Tool for Analyzing PEGylated Proteins

Ligand® Pharmaceuticals Inc. had an excellent success utilizing YMC’s BioProIEX to analyze PEGylated protein charge variants reproducibly. They developed a characterization method for PEGylated biotherapeutic proteins that can provide increased information without compromising peak shape and resolution and wanted to
YMC Launches New Laboratories

August 24, 2021

YMC Launches New Laboratories

YMC has significantly expanded its lab capabilities in the USA by opening labs in Devens, MA and Thousand Oaks, CA (USA) to complement their long-standing partner lab in Maryland. Much more than testing or demo labs, YMC will be using

Designed and developed by